Abstract
Aim. To provide an overview of current knowledge on pharmacotherapy of premature ejaculation (PE). Materials and Methods. A comprehensive review of the literature was conducted using MEDLINE and analysis of crossreferences. The key points of methodology and pharmacology of various articles have been analysed and critically reviewed. Results. PE may have significant negative impact on quality of life. Various recommendations for drug treatment of PE have been found in the available literature, varying from anesthetic ointments to various antidepressants and phosphodiesterase inhibitors. Due to disturbing side effects, various drugs are not suitable for general use. On the other hand, topical anesthetics, clomipramine and some SSRIs have repeatedly been found safe and effective to delay ejaculation. Conclusions. Remarkable progress has been made in the treatment of PE. Further research into the neural, psychological and molecular mechanisms involved in PE will lead to the development of even safer, more effective and more convenient therapies for men with PE.
Keywords: Premature ejaculation, treatment, diagnosis
Current Drug Therapy
Title: Pharmacotherapy for Premature Ejaculation
Volume: 1 Issue: 1
Author(s): M. R. Safarinejad and S. Y. Hosseini
Affiliation:
Keywords: Premature ejaculation, treatment, diagnosis
Abstract: Aim. To provide an overview of current knowledge on pharmacotherapy of premature ejaculation (PE). Materials and Methods. A comprehensive review of the literature was conducted using MEDLINE and analysis of crossreferences. The key points of methodology and pharmacology of various articles have been analysed and critically reviewed. Results. PE may have significant negative impact on quality of life. Various recommendations for drug treatment of PE have been found in the available literature, varying from anesthetic ointments to various antidepressants and phosphodiesterase inhibitors. Due to disturbing side effects, various drugs are not suitable for general use. On the other hand, topical anesthetics, clomipramine and some SSRIs have repeatedly been found safe and effective to delay ejaculation. Conclusions. Remarkable progress has been made in the treatment of PE. Further research into the neural, psychological and molecular mechanisms involved in PE will lead to the development of even safer, more effective and more convenient therapies for men with PE.
Export Options
About this article
Cite this article as:
Safarinejad R. M. and Hosseini Y. S., Pharmacotherapy for Premature Ejaculation, Current Drug Therapy 2006; 1 (1) . https://dx.doi.org/10.2174/157488506775268434
DOI https://dx.doi.org/10.2174/157488506775268434 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patents in Targets and Drugs for Insulin Resistance: Correlation with Inflammatory Mediators
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Editorial [Hot topic: Transportalopathy and Vascular Cell Dysfunction (Guest Editor: Luis Sobrevia)]
Current Vascular Pharmacology Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors
Current Medicinal Chemistry Diabetes, the Renin-Angiotensin System and Heart Disease
Current Vascular Pharmacology Association between HbA1C (Glycated Hemoglobin) and Clinical Outcomes in Patients with Subarachnoid Hemorrhage After Neuro-intervention
Current Neurovascular Research Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Current Pharmaceutical Design Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis
Current Drug Targets Calcitonin Gene-Related Family Peptides in Vascular Adaptations, Uteroplacental Circulation, and Fetal Growth
Current Vascular Pharmacology Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis
Current Molecular Medicine Subject Index to Volume 10
Current Pharmaceutical Design Multifunctional RNase MCPIP1 and its Role in Cardiovascular Diseases
Current Medicinal Chemistry Benzodiazepines, Amphetamines, Testosterone, and Sildenafil as New Candidate Drugs for Sexual Interest, Desire and/or Arousal Disorder
Current Psychopharmacology Isolation and Boactivities of Furfuran Type Lignan Compounds from Edible Plants
Recent Patents on Food, Nutrition & Agriculture Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
Current Vascular Pharmacology Transfection of TGF-β shRNA by Using Ultrasound-targeted Microbubble Destruction to Inhibit the Early Adhesion Repair of Rats Wounded Achilles Tendon In vitro and In vivo
Current Gene Therapy Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers
Current Drug Therapy Evidence for the Involvement of Resistin in Inflammation and Cardiovascular Disease
Current Diabetes Reviews Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases
Current Topics in Medicinal Chemistry